ADVFN - Advanced Financial Network.
HOME» NYSE » B » BCR Stock Price » BCR Stock News

Bard C R Share News

 Bard (c.r.), Inc. Stock Price
BCR Stock Price
 Bard (c.r.), Inc. Stock Chart
BCR Stock Chart
 Bard (c.r.), Inc. Stock News
BCR Stock News
 Bard (c.r.), Inc. Company Information
BCR Company Information
 Bard (c.r.), Inc. Stock Trades
BCR Stock Trades

CR Bard Financial Chief Schermerhorn To Retire

DOW JONES NEWSWIRES Medical-device maker C.R. Bard Inc. (BCR) disclosed a change in a top post Monday, announcing the retirement of its chief financial officer after more than 25 years with the company. Todd C. Schermerhorn joined the company in 1985 as a financial analyst. He has served in various positions throughout his tenure, including controller of the vascular systems division. He stepped into the chief financial post in 2003. "Todd's leadership has been invaluable to Bard in shaping our strategy and culture. His tireless commitment and passion for excellence have influenced our organization across every function and at every level," said Chief Executive Timothy M. Ring. The company didn't name an immediate successor, instead noting that Schermerhorn will stay on for a transition period and serve as chief financial officer until a successor is elected. A rebound in spending in the health-care sector has driven renewed profits at companies like C.R. Bard, which has reported solid revenue growth on a strong performance in the vascular business, its largest by revenue. Last month, the company reported it swung to a second-quarter loss as a hefty charge related to a legal settlement masked revenue growth across all product categories. Shares of C.R. Bard rose 69 cents to $99.37 recently. The stock is up about 8.2% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Bard C R (BCR)
DateTimeHeadline
11/30/201610:30:00Bard to Present at the Citi Healthcare Conference
11/23/201610:30:00Bard to Present at the Piper Jaffray Healthcare Conference
11/22/201614:17:46Current Report Filing (8-k)
11/08/201610:30:00Bard to Present at the Stifel Healthcare Conference
10/31/201616:36:04Statement of Changes in Beneficial Ownership (4)
10/26/201613:12:12Quarterly Report (10-q)
10/25/201616:33:53Current Report Filing (8-k)
10/25/201616:15:00Bard Announces Third Quarter Results
10/21/201609:01:33Current Report Filing (8-k)
10/12/201616:15:00Bard Declares Quarterly Dividend
10/03/201610:30:00Bard to Host Earnings Conference Call on October 25, 2016
09/30/201609:00:00The Medical Device Industry's Focus on Cardio and Cardiovascular...
09/29/201616:16:18Statement of Changes in Beneficial Ownership (4)
09/27/201616:07:29Statement of Changes in Beneficial Ownership (4)
09/22/201608:30:00LUTONIX® Global Real-World Registry 24-Month Outcomes Presented...
09/20/201615:26:04Statement of Changes in Beneficial Ownership (4)
09/19/201617:37:00FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee...
09/08/201609:45:24Statement of Changes in Beneficial Ownership (4)
09/08/201609:44:57Statement of Changes in Beneficial Ownership (4)
09/06/201611:00:00Bard to Present at Morgan Stanley Global Healthcare Conference

Bard C R and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US